Log in or Sign up for Free to view tailored content for your specialty!
Neuro-Oncology News
Trial to assess personalized vaccine for aggressive brain tumors
A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.
Young children treated for brain tumors less ready for school than their peers
Young children who underwent treatment for brain tumors had lower academic readiness scores than their peers, according to results of a prospective longitudinal trial.
Drug shows ‘very promising’ activity in breast cancer brain metastases
Sacituzumab govitecan-hziy exhibited efficacy as therapy for two traditionally difficult-to-treat populations, according to results of a window-of-opportunity trial.
Log in or Sign up for Free to view tailored content for your specialty!
Spouses of people with cancer more likely to attempt, die of suicide
Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.
Healio wins APEX award for Psychedelics & Alternative Therapies collection
The Healio news staff received an APEX award in the category of Writing/Topics for work on the potential role of psychedelics and alternative therapies for mental health issues and other medical conditions.
VIDEO: Study investigates use of oncolytic measles virus to treat pediatric brain tumors
PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the PNOC005 trial she presented at International Symposium on Pediatric Neuro-Oncology.
VIDEO: Study investigates novel therapy for penetration of pediatric brain tumors
PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the PNOC016 trial she presented at International Symposium on Pediatric Neuro-Oncology.
1 in 6 Americans live at least 4 hours from proton beam therapy facility
More than 16% of Americans live at least a 4-hour drive from the closest proton beam therapy facility, according to data published in JAMA Network Open.
FDA approves Voranigo for astrocytoma, oligodendroglioma
The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma.
VIDEO: Tovorafenib for low-grade gliomas shows decreased tumor growth in phase 2 study
PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the FIREFLY-1 (NCT04775485) trial she presented at International Symposium on Pediatric Neuro-Oncology.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read